Jun 02, 2026

Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns

Read more

Jun 02, 2026

High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

Read more

Jun 02, 2026

Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns Read more at: https://pharma.economictimes.indiatimes.com/news/pharma-industry/fulcrum-scraps-sickle-cell-drug-program-after-fda-raises-cancer-risk-concerns/131452683

Read more

Jun 02, 2026

High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

Read more

Jun 01, 2026

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Read more

May 30, 2026

Prevalence of Alloantibodies in Sickle Cell Disease and its Impact in Low-Resource Countries

Read more

May 29, 2026

Evaluating the Diagnostic Performance of AI and Machine Learning in Sickle Cell Disease Detection: A Systematic Review

Read more

May 29, 2026

Govt paying special attention to anaemia, sickle cell anaemia in tribal areas, says Health Minister

Read more

May 29, 2026

Agios’ next-gen PK drug fails blood cancer study but sickle cell disease ambitions remain undimmed

Read more

May 28, 2026

Genetic variants in red blood cell adhesion-related genes influence the severity of sickle cell anemia in a malaria-endemic region : Short title: Genetic variants in red blood cell adhesion-related genes in sickle cell anemia

Read more

Subscribe to